449 Spam-Free Article(s) Found
Sort:
Date
Filter:
All
Symbol Name Last Close Mkt Cap DailyStocks'
Rating
Our DailyStocks’ Rating System is a proprietary algorithm that combines the vote of the investor community and legendary trader Richard Dennis’ Turtle Trader System and the System Rules of the Turtle Traders Each day, we generate Buy, Sell, Uptrend or Downtrend signals for 3000 Stocks in the U.S. Markets.
Vote Now!
Tuesday’s Close
SNY Sanofi $43.75 $109.14B N/A
Article Searches
Pharma Stock Roundup: Mylan, Endo Report 4Q Results, FDA Nod for AZN Diabetes Drug http://www.zacks.com/stock/news/251551/pharma-stock-roundup-mylan-endo-report-4q-results-fda-nod-for-azn-diabetes-drug?cid=CS-ZC-FT-251551 Mar 03, 2017 - Quite a few companies including AstraZeneca (AZN) provided pipeline/regulatory updates this week.
Zacks Industry Outlook Highlights: Sanofi, AstraZeneca, Novo Nordisk, Gilead Sciences and Valeant Pharmaceuticals International http://www.zacks.com/stock/news/251359/zacks-industry-outlook-highlights-sanofi-astrazeneca-novo-nordisk-gilead-sciences-and-valeant-pharmaceuticals-international?cid=CS-ZC-FT-251359 Mar 02, 2017 - Zacks Industry Outlook Highlights: Sanofi, AstraZeneca, Novo Nordisk, Gilead Sciences and Valeant Pharmaceuticals International
Pricing to Remain Pharma Headline Risk in 2017 http://www.zacks.com/commentary/105146/pricing-to-remain-pharma-headline-risk-in-2017?cid=CS-ZC--105146 Mar 01, 2017 - Pricing to Remain Pharma Headline Risk in 2017
M&As, Pipeline Catalysts to Drive Pharma Sector http://www.zacks.com/commentary/105123/mas-pipeline-catalysts-to-drive-pharma-sector?cid=CS-ZC--105123 Mar 01, 2017 - M&As, Pipeline Catalysts to Drive Pharma Sector
New Analyst Reports for Google, Chevron, Altria & Others http://www.zacks.com/research-daily/87549/new-analyst-reports-for-google-chevron-altria-others?cid=CS-ZC-FT-87549 Aug 03, 2016 - New Analyst Reports for Google, Chevron, Altria & Others
Sanofi (SNY) Posts In-Line Q2 Earnings, Revenues Down Y/Y http://www.zacks.com/stock/news/226172/sanofi-sny-posts-in-line-q2-earnings-revenues-down-y-y?cid=CS-ZC-FT-226172 Aug 01, 2016 - Sanofi (SNY) reported second-quarter 2016 business earnings of 74 cents per American Depositary Share, in line with the Zacks Consensus Estimate.
Regeneron (REGN) Q2 Earnings: Can the Stock Surprise? http://www.zacks.com/stock/news/226136/regeneron-regn-q2-earnings-can-the-stock-surprise?cid=CS-ZC-FT-226136 Aug 01, 2016 - Regeneron Pharmaceuticals (REGN), which is set to release second-quarter 2016 results on Aug 4, had recorded an average negative earnings surprise of 0.06% last quarter.
Sanofi (SNY) Olivier Brandicourt on Q2 2016 Results - Earnings Call Transcript http://seekingalpha.com/article/3993329-sanofi-sny-olivier-brandicourt-q2-2016-results-earnings-call-transcript?source=feed_sector_healthcare Jul 29, 2016 - Sanofi (NYSE:SNY)Q2 2016 Earnings CallJuly 29, 2016 8:30 am ETExecutivesGeorge Grofik - Vice President Investor Relations, SanofiOlivier Brandicourt - Chief Executive Officer & DirectorElias E. Zerhou
CNBC: Medivation sets mid-August deadline; SNY, PFE, GILD, CELG in play http://seekingalpha.com/news/3197917-cnbc-medivation-sets-mid-august-deadline-sny-pfe-gild-celg-play?source=feed_news_all Jul 29, 2016 - Medivation (MDVN +1.3%) has asked for indications of interest by mid-August, CNBC's David Faber says, with a number of pursuers in the mix. Earlier this mo
Bristol-Myers (BMY): Stock to Beat Earnings Again in Q2 http://www.zacks.com/stock/news/224851/bristol-myers-bmy-stock-to-beat-earnings-again-in-q2?cid=CS-ZC-FT-224851 Jul 25, 2016 - Bristol-Myers Squibb (BMY), which is set to report second-quarter 2016 results on Jul 28, reported a positive earnings surprise of 12.12% last quarter.

Pages: 1...3839404142434445

<<<Page 43>